Medical Effect LT, UAB - financials and debts

Company age: 10 y. 6 mo.

Update

Medical Effect LT - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 32,815 46,090 1,228,819 1,368,719 597,762 53,405 87,313 13,740
Profit before tax -4,620 36,861 224,746 132,087 6,703 1,752 2,985 1,945
Net profit -4,620 32,993 191,034 112,274 5,698 1,489 2,537 1,634
Equity 5,929 38,922 196,963 151,735 143,876 115,784 27,636 30,806
Liabilities 172,131 150,812 401,720 209,837 20,866 5,182 3,146 2,489
Non-current assets 0 0 4,748 5,559 3,808 1,759 546 380
Current assets 178,060 189,734 593,935 356,013 160,934 119,207 30,236 32,915
Total assets 178,060 189,734 598,683 361,572 164,742 120,966 30,782 33,295
Taxes paid
STI taxes - - - - - 15,678 3,236 1,079
Financial indicators
Revenue change y/y -10.7% +40.5% +2566.1% +11.4% -56.3% -91.1% +63.5% -84.3%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -2.6% 17.4% 31.9% 31.1% 3.5% 1.2% 8.2% 4.9%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. -77.9% 84.8% 97.0% 74.0% 4.0% 1.3% 9.2% 5.3%
Profit margin Net profit margin. Shows the overall profitability of the company. -14.1% 71.6% 15.5% 8.2% 1.0% 2.8% 2.9% 11.9%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -14.1% 80.0% 18.3% 9.7% 1.1% 3.3% 3.4% 14.2%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 29.0 3.9 2.0 1.4 0.1 0.0 0.1 0.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 7,203 9,536 1,228,819 1,368,719 597,762 53,405 87,313 13,740

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Medical Effect LT - Social security debts

The amount of overdue SODRA debt for the company Medical Effect LT as of the last working day is: 18 €

From To Debt, €
2026-09-16 2026-09-17 18.22
2026-09-05 2026-09-15 6.08
2026-08-26 2026-09-02 21.08
2026-08-23 2026-08-23 21.08
2026-08-19 2026-08-19 21.08
2026-08-16 2026-08-17 8.94
2026-08-04 2026-08-14 8.94
2026-06-16 2026-07-12 14.54
2026-06-11 2026-06-15 2.40
2026-05-17 2026-06-08 17.40
2026-05-03 2026-05-14 5.26
2026-04-27 2026-04-29 5.26
2026-04-26 2026-04-26 5.11
2026-04-23 2026-04-25 5.26
2026-04-20 2026-04-22 5.11
2026-03-29 2026-04-12 19.97
2026-03-17 2026-03-27 19.97
2026-01-21 2026-01-22 6.43
2026-01-16 2026-01-20 6.40
2025-12-16 2025-12-30 7.13
2025-08-28 2025-08-29 21.90
2025-08-19 2025-08-26 21.90
2025-04-16 2025-04-17 18.97
2025-02-10 2025-02-10 28.39
2025-01-16 2025-02-03 28.39
2024-08-19 2024-08-20 46.17
2024-07-16 2024-07-17 60.62
2024-06-18 2024-06-24 33.56
2024-04-16 2024-04-28 19.20
2023-07-24 2023-07-25 37.77
2023-07-18 2023-07-23 37.58
2023-06-16 2023-07-03 32.96
2023-03-16 2023-03-19 40.21
2023-01-17 2023-01-18 70.65
2022-10-18 2022-11-02 50.92

Medical Effect LT - VMI tax arrears

From To Overdue, €
2026-05-19 2026-05-20 5.34
2026-04-14 2026-04-20 5.22
2026-03-27 2026-04-12 0.22
2026-03-20 2026-03-26 20.68
2026-03-17 2026-03-18 20.34
2026-02-07 2026-03-16 0.34
2026-02-03 2026-02-06 19.73
2026-01-16 2026-02-02 19.42
2025-12-17 2025-12-18 11.42
2025-11-02 2025-11-08 1022.16
2025-10-30 2025-11-01 1021.08

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Medical Effect LT, UAB (code 304207608) is a private limited liability company operating in new construction. In 2025, the company generated revenue of €13.7K and net profit of €1.6K, with a profit margin of 11.9%. Revenue declined sharply from €87.3K in 2024 to €13.7K in 2025, while net profit remained positive after €2.5K in 2024 and €1.5K in 2023. Over the three-year period, profitability improved relative to turnover, even as activity contracted. The 2025 balance sheet shows total assets of €33.3K, equity of €30.8K and liabilities of €2.5K, indicating a strong equity position and low leverage. The equity ratio stood at 92.5%, debt-to-equity at 0.08, ROE at 5.3% and ROA at 4.9%. Asset turnover was 0.41x. Revenue per employee was €13.7K and profit per employee €1.6K, based on the available staff data. Compared with 2023, when revenue was €53.4K and net profit €1.5K, the company shows a lower scale of operations in 2025 but continued positive earnings.